Gene expression-targeted isoflavone therapy
نویسندگان
چکیده
منابع مشابه
gene expression profiling for cancer targeted therapy
background : lung cancer is still the leading cause of cancer- related deaths and most of themâ are normally diagnosed in late stages, so there is an urgent need to establish reliable tools for the identification at early stages of the disease. in this study, we use an eleven gene signature test to examine lung biopsy specimens for diagnostic, prognostic & therapeutic purposes. methods : bronc...
متن کاملTargeted gene therapy in radiotherapy
Radiotherapy is the use of ionizing radiation in the treatment of malignant tumors. It is one of the main treatment modalities for many forms of cancer, with more than half of all cancer patients receiving radiation therapy at some point in their treatment.1 Biological and technological advances have brought notable improvements in radiotherapy over the years. Biologically based advances includ...
متن کاملCancer Gene Therapy: Targeted Genomedicines
Given the fact that malignant cells proliferate more rapidly than normal cells, damage to the cancer cells is anticipated to be markedly greater than normal cells. However, cancer cells generate chemoresistance mechanisms within the tumor microenvironment, while undesired toxicity may occur in the normal cells. For example, in colorectal cancer (CRC), there exist well-described sequences of mut...
متن کاملGene Expression and Isoflavone Concentrations in Soybeans Treated with Chitosan
Isoflavones in soybean seeds have putative health-beneficial effects. Previous studies demonstrated that foliar application of chitosan could increase soybean isoflavone concentrations. In this study we determined the impact of different chitosan solutions on gene expression and isoflavone concentrations of two soybean cultivars [AC Orford (low isoflavone cultivar) and AC Proteina (high isoflav...
متن کاملResistance to HER2-targeted therapy
Production and approval of trastuzumab (Herceptin®) for the treatment of metastatic breast cancer (MBC) was a millstone in antibody-based targeted therapy in the cancer treatment. However, despite the early success in the clinical trials, trastuzumab failed to appreciate the initial attraction due to development of resistance to the drug. The majority of patients who benefit from the drug...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: IUBMB Life
سال: 2012
ISSN: 1521-6543
DOI: 10.1002/iub.1007